Cytotoxic and anti-mitotic compounds, and methods of using the same
AssigneeZymeworks BC Inc.
InventorsGeoffrey C. Winters, Alexander Laurence Mandel, James R. Rich, Bradley John Hedberg, Tom Han Hsiao Hsieh, Elyse Marie Josée Bourque, John Babcook
Life of this patent
Estimating the term…
Abstract
Compounds having cytotoxic and/or anti-mitotic activity are disclosed. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed. Also disclosed are compositions having the structure: (T)-(L)-(D), wherein (T) is a targeting moiety, (L) is an optional linker, and (D) is a compound having cytotoxic and/or anti-mitotic activity.
Claims23
A conjugate having the following structure:
- (T)-(L)-(PT) (VII)
- wherein (T) is a targeting moiety, wherein the targeting moiety comprises an antibody or an antigen-binding antibody fragment,
- (L) is a linker, and
- (PT) is a hemiasterlin analog, and
- wherein (T)-(L)-(PT) has the following structure:
- wherein:
- R15 is selected from the group consisting of optionally substituted alkyl, optionally substituted alkylamino, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl and optionally substituted heteroaryl;
- R16 and R17 are independently selected from the group consisting of H and C1-6 alkyl;
- R18 and R30 are independently selected from the group consisting of H, C1-6 alkyl and —SH, with the proviso that R18 and R30 cannot both be H;
- R32 is:
- Z is selected from the group consisting of:
- —OH;
- —OR;
- —SH;
- —SR;
- —NH2;
- —NRCH(R11)COOH;
- and —NHCH(R11)COOH, wherein R11 is R or —(CH2)nNR12R13, wherein n=1−4 and R12 and R13 are independently selected from the group consisting of:
- H, R and —C(NH)(NH2);
- R is a saturated or unsaturated linear or branched alkyl containing one to ten carbon atoms, or a cycloalkyl or heterocyclyl containing three to ten carbon atoms and zero to four nitrogen atoms, wherein the carbon atoms are optionally independently substituted with:
- ═O, ═S, OH, —OR10, —O2CR10, —SH, —SR10, —SOCR10, —NH2, —NHR10, —N(R10)2, —NHCOR10, —NR10COR10, —I, —Br, —Cl, —F, —CN, —CO2H, —CO2R10, —CHO, —COR10, —CONH2, —CONHR10, —CON(R10)2, —COSH, —COSR10, —NO2, —SO3H, —SOR10, or —SO2R10, wherein R10 is a linear or branched one to ten carbon saturated or unsaturated alkyl group or a three to ten carbon cycloalkyl;
- Y is a linear, saturated or unsaturated, one to six carbon alkyl group, optionally substituted with R, and
- R14 is selected from the group consisting of optionally substituted alkyl, optionally substituted alkylamino, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heterocyclyl and optionally substituted heteroaryl.
A conjugate having the following structure:
- (T)-(L)-(PT) (VII)
- wherein:
- (T) is a targeting moiety, wherein the targeting moiety comprises an antibody or an antigen-binding antibody fragment,
- (L) is a linker, and
- (PT) is a hemiasterlin analog, and
- wherein (T)-(L)-(PT) has the following structure:
- wherein:
- R is a saturated or unsaturated linear or branched alkyl containing one to ten carbon atoms, or a cycloalkyl or heterocyclyl containing three to ten carbon atoms and zero to four nitrogen atoms, wherein the carbon atoms are optionally independently substituted with:
- ═O, ═S, OH, —OR10, —OCR10, —SH, —SR10, —SOCR10, —NH2, —NHR10, —N(R10)2, —NHCOR10, —NR10COR10, —I, —Br, —Cl, —F, —CN, —CO2H, —CO2R10, —CHO, —COR10, —CONH2, —CONHR10, —CON(R10)2, —COSH, —COSR10, —NO2, —SO3H, —SOR10, or —SO2R10, wherein R10 is a linear or branched one to ten carbon saturated or unsaturated alkyl group or a three to ten carbon cycloalkyl.
A conjugate having the following structure:
- (T)-(L)-(PT) (VII)
- wherein:
- (T) is a targeting moiety, wherein the targeting moiety comprises an antibody or an antigen-binding antibody fragment,
- (L) is a linker, and
- (PT) is a hemiasterlin analog, and
- wherein (T)-(L)-(PT) has the following structure:
- wherein:
- R is a saturated or unsaturated linear or branched alkyl containing one to ten carbon atoms, or a cycloalkyl or heterocyclyl containing three to ten carbon atoms and zero to four nitrogen atoms, wherein the carbon atoms are optionally independently substituted with:
- ═O, ═S, OH, —OR10, —O2CR10, —SH, —SR10, —SOCR10, —NH2, —NHR10, —N(R10)2, —NHCOR10, —NR10COR10, —I, —Br, —Cl, —F, —CN, —CO2H, —CO2R10, —CHO, —COR10, —CONH2, —CONHR10, —CON(R10)2, —COSH, —COSR10, —NO2, —SO3H, —SOR10, or —SO2R10, wherein R10 is a linear or branched one to ten carbon saturated or unsaturated alkyl group or a three to ten carbon cycloalkyl.
Dependencies are inferred from the claim text.